Caihong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Caihong Wang has a total of 171 co-authors. Here are the top co-authors by number of shared publications:
Chong Gao
Pathology, Joint Program in Transfusion Medicine, Brigham and Women’s Hospital/Children’s Hospital, Harvard Medical School, Boston, USA
48 shared publicationsXiaofeng Li
Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
37 shared publicationsRui Su
Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China
24 shared publicationsRuihe Wu
Department of Rheumatology, the Second Hospital of Shanxi Medical University
19 shared publicationsBaochen Li
Department of Rheumatology, the Second Hospital of Shanxi Medical University
16 shared publicationsHuanhuan Yan
Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China
9 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Springer Nature in Arthritis Research & Therapy
Peripheral immune cell and circulating cytokine alterations associated with hematologic involvement in primary Sjögren’s syndrome
- 28 October 2026
- Published by Springer Nature in Arthritis Research & Therapy
Open AccessPeripheral immune cell and circulating cytokine alterations associated with hematologic involvement in primary Sjögren’s syndrome
- 5 September 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Comprehensive risk factor control attenuates excess cardiovascular risk in rheumatoid arthritis: a prospective cohort study
Objective: Rheumatoid arthritis (RA) confers substantially elevated cardiovascular disease (CVD) risk. We quantified the association between joint risk factor control and incident CVD among RA patients and examined modification by genetic susceptibility. Methods and results: In this prospective UK Biobank cohort, 4426 RA patients and 17 704 matched non-RA controls were followed for CVD, coronary heart disease (CHD), stroke, and heart failure. A nine-component risk factor control score (0–9) was constructed, incorporating healthy diet, smoking, physical activity, blood pressure, glycated haemoglobin, low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, body mass index, and estimated glomerular filtration rate. Cox models, sensitivity analyses, and restricted mean survival time (RMST) were applied. Least absolute shrinkage and selection operator regression identified CVD-predictive metabolomic features; mediation analysis quantified the metabolomic risk score (MRS) contribution. Polygenic risk score joint analyses assessed genetic effect modification. Better control was associated with graded CVD risk reduction [moderate: hazard ratio (HR) 0.77, 95% CI: 0.64–0.93; high: HR 0.46, 95% CI: 0.33–0.64 vs. low]. High control yielded CVD and CHD risks comparable to non-RA controls and lower stroke risk (HR 0.34, 95% CI: 0.13–0.91). RMST showed +3.58 CVD-free years (95% CI: 2.49–4.68; P < 0.001). Mediation indicated partial MRS mediation (indirect proportion 34.1%; 20.8% adjusted). No significant interaction with MRS; high control attenuated risk even in high genetic risk. Conclusion: Comprehensive control attenuates and may offset RA-excess CVD risk, even with high genetic susceptibility. The effect is partially metabolically mediated yet independent of metabolic status, supporting dual-pathway prevention.
- 5 September 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Comprehensive risk factor control attenuates excess cardiovascular risk in rheumatoid arthritis: a prospective cohort study
Objective: Rheumatoid arthritis (RA) confers substantially elevated cardiovascular disease (CVD) risk. We quantified the association between joint risk factor control and incident CVD among RA patients and examined modification by genetic susceptibility. Methods and results: In this prospective UK Biobank cohort, 4426 RA patients and 17 704 matched non-RA controls were followed for CVD, coronary heart disease (CHD), stroke, and heart failure. A nine-component risk factor control score (0–9) was constructed, incorporating healthy diet, smoking, physical activity, blood pressure, glycated haemoglobin, low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, body mass index, and estimated glomerular filtration rate. Cox models, sensitivity analyses, and restricted mean survival time (RMST) were applied. Least absolute shrinkage and selection operator regression identified CVD-predictive metabolomic features; mediation analysis quantified the metabolomic risk score (MRS) contribution. Polygenic risk score joint analyses assessed genetic effect modification. Better control was associated with graded CVD risk reduction [moderate: hazard ratio (HR) 0.77, 95% CI: 0.64–0.93; high: HR 0.46, 95% CI: 0.33–0.64 vs. low]. High control yielded CVD and CHD risks comparable to non-RA controls and lower stroke risk (HR 0.34, 95% CI: 0.13–0.91). RMST showed +3.58 CVD-free years (95% CI: 2.49–4.68; P < 0.001). Mediation indicated partial MRS mediation (indirect proportion 34.1%; 20.8% adjusted). No significant interaction with MRS; high control attenuated risk even in high genetic risk. Conclusion: Comprehensive control attenuates and may offset RA-excess CVD risk, even with high genetic susceptibility. The effect is partially metabolically mediated yet independent of metabolic status, supporting dual-pathway prevention.
- Open Access
- 4 September 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1941650
Immunological dysregulation of follicular helper T cells, follicular regulatory T cells, and follicular cytotoxic T cells is associated with disease activity and identifies exploratory immune patterns in rheumatoid arthritis
Background: The onset and progression of rheumatoid arthritis (RA) are linked to autoantibody production driven by dysregulated germinal center (GC) responses. Follicular helper T cells (Tfh), follicular regulatory T cells (Tfr), and follicular cytotoxic T cells (Tfc) are important components of follicular immune regulation. However, the circulating profiles and clinical associations of these three cell subsets in the peripheral blood of RA patients remain underexplored through systematic investigations, and the specific function of Tfc cells in RA remains incompletely understood. Methods: In the present study, peripheral blood samples were collected from 41 patients with RA and 16 healthy controls (HCs). Modified flow cytometry was employed to detect circulating Tfh, Tfr, and Tfc cells, with the aim of systematically investigating the clinical and immunological implications of these cell subsets in RA. Results: (1) RA patients exhibited a disrupted Tfh/Tfr ratio in peripheral blood, accompanied by an elevated proportion of Tfc cells, both of which correlated with disease activity and autoantibody levels. (2) The ratio of Tfh/Tfr and the proportion of Tfc cells were significantly increased in patients with high disease activity of RA. (3) The frequency of Tfc cells showed a positive correlation with the frequency of Tfh cells and soluble interleukin-2 receptor (sIL-2R) levels. (4) Based on k-means unsupervised clustering analysis, patients with RA were grouped into three exploratory follicular T-cell-associated immune patterns: Cluster 3 patients displayed the highest disease activity, while Cluster 2 patients presented with the lowest white blood cell count. Conclusion: The dynamic imbalance of the circulating Tfh/Tfr/Tfc cells may reflect immune dysregulation in RA. The expansion of Tfc cells may be associated with systemic immune activation in RA. Exploratory clustering analysis further identified distinct follicular T-cell-associated immune patterns, providing new insights into RA immunological heterogeneity.
- 4 September 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1941650
Open AccessImmunological dysregulation of follicular helper T cells, follicular regulatory T cells, and follicular cytotoxic T cells is associated with disease activity and identifies exploratory immune patterns in rheumatoid arthritis
Background: The onset and progression of rheumatoid arthritis (RA) are linked to autoantibody production driven by dysregulated germinal center (GC) responses. Follicular helper T cells (Tfh), follicular regulatory T cells (Tfr), and follicular cytotoxic T cells (Tfc) are important components of follicular immune regulation. However, the circulating profiles and clinical associations of these three cell subsets in the peripheral blood of RA patients remain underexplored through systematic investigations, and the specific function of Tfc cells in RA remains incompletely understood. Methods: In the present study, peripheral blood samples were collected from 41 patients with RA and 16 healthy controls (HCs). Modified flow cytometry was employed to detect circulating Tfh, Tfr, and Tfc cells, with the aim of systematically investigating the clinical and immunological implications of these cell subsets in RA. Results: (1) RA patients exhibited a disrupted Tfh/Tfr ratio in peripheral blood, accompanied by an elevated proportion of Tfc cells, both of which correlated with disease activity and autoantibody levels. (2) The ratio of Tfh/Tfr and the proportion of Tfc cells were significantly increased in patients with high disease activity of RA. (3) The frequency of Tfc cells showed a positive correlation with the frequency of Tfh cells and soluble interleukin-2 receptor (sIL-2R) levels. (4) Based on k-means unsupervised clustering analysis, patients with RA were grouped into three exploratory follicular T-cell-associated immune patterns: Cluster 3 patients displayed the highest disease activity, while Cluster 2 patients presented with the lowest white blood cell count. Conclusion: The dynamic imbalance of the circulating Tfh/Tfr/Tfc cells may reflect immune dysregulation in RA. The expansion of Tfc cells may be associated with systemic immune activation in RA. Exploratory clustering analysis further identified distinct follicular T-cell-associated immune patterns, providing new insights into RA immunological heterogeneity.
- Open Access
- 1 July 2026
- Published by Springer Nature in Inflammation
- Vol. 49 (1)
Opposing Dynamics of CD4 + Regulatory and CD8 + Foxp3+ T Cells Characterize Immune Imbalance in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease marked by persistent inflammation and joint damage from impaired immune tolerance. While CD4 + regulatory T cells (Tregs) are key to immune balance, their ability to restore tolerance in RA remains insufficient. Recently, CD8 + Foxp3+T have emerged as distinct regulators of immune tolerance, and investigating their role may provide new insights into the pathogenesis of RA. We enrolled 51 RA patients and 27 healthy controls. RA patients were grouped by disease activity: low-to-moderate (L-M RA) or high (H RA). We analyzed clinical data and lymphocyte subsets, including CD4 + Tregs and CD8 + Foxp3+T, to identify key immunological differences between RA and HC. Internal validation was performed using bootstrapping, and P-values were adjusted for false discovery rate (FDR) to ensure robustness. (1) CD4 + Tregs decreased in RA, especially in H RA, while CD8 + Foxp3+T increased, most in L-M RA. (2) CD4 + Tregs correlated negatively with IL-2, IL-4, and IL-10, whereas CD8 + Foxp3+T correlated negatively with ESR, DAS28, and RF-IgA/IgG. (3) The CD4 + Treg/CD8 + Foxp3+T ratio distinguished RA from controls. The combined model (including TNF-α and CD4 + Treg%) demonstrated strong discrimination with an AUC of 0.928 (optimism-corrected AUC: 0.912). CD8 + Foxp3+ T were increased in patients with RA and exhibited a trend opposite to that of CD4 + Treg. These two cell populations were associated with disease activity from distinct immunological perspectives. Furthermore, the CD4 + Treg/CD8 + Foxp3+T ratio and the combination of CD4 + Treg% with TNF-α showed potential value in distinguishing patients with RA from healthy controls. These findings provide additional insight into the immunological characteristics of RA and support further investigation into the biological significance of CD8 + Foxp3+ T cells.
- 1 July 2026
- Published by Springer Nature in Inflammation
- Vol. 49 (1)
Open AccessOpposing Dynamics of CD4 + Regulatory and CD8 + Foxp3+ T Cells Characterize Immune Imbalance in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease marked by persistent inflammation and joint damage from impaired immune tolerance. While CD4 + regulatory T cells (Tregs) are key to immune balance, their ability to restore tolerance in RA remains insufficient. Recently, CD8 + Foxp3+T have emerged as distinct regulators of immune tolerance, and investigating their role may provide new insights into the pathogenesis of RA. We enrolled 51 RA patients and 27 healthy controls. RA patients were grouped by disease activity: low-to-moderate (L-M RA) or high (H RA). We analyzed clinical data and lymphocyte subsets, including CD4 + Tregs and CD8 + Foxp3+T, to identify key immunological differences between RA and HC. Internal validation was performed using bootstrapping, and P-values were adjusted for false discovery rate (FDR) to ensure robustness. (1) CD4 + Tregs decreased in RA, especially in H RA, while CD8 + Foxp3+T increased, most in L-M RA. (2) CD4 + Tregs correlated negatively with IL-2, IL-4, and IL-10, whereas CD8 + Foxp3+T correlated negatively with ESR, DAS28, and RF-IgA/IgG. (3) The CD4 + Treg/CD8 + Foxp3+T ratio distinguished RA from controls. The combined model (including TNF-α and CD4 + Treg%) demonstrated strong discrimination with an AUC of 0.928 (optimism-corrected AUC: 0.912). CD8 + Foxp3+ T were increased in patients with RA and exhibited a trend opposite to that of CD4 + Treg. These two cell populations were associated with disease activity from distinct immunological perspectives. Furthermore, the CD4 + Treg/CD8 + Foxp3+T ratio and the combination of CD4 + Treg% with TNF-α showed potential value in distinguishing patients with RA from healthy controls. These findings provide additional insight into the immunological characteristics of RA and support further investigation into the biological significance of CD8 + Foxp3+ T cells.
- Open Access
- 9 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1844268
Soluble IL-2 receptor and memory Treg profiles differentiate early rheumatoid arthritis from undifferentiated arthritis at initial presentation
Background: Rheumatoid arthritis (RA) is a significant global health issue. Early diagnosis remains clinically challenging, particularly in patients with inflammatory arthritis who do not yet fulfill 2010 ACR/EULAR classification criteria (undifferentiated arthritis, UA). Methods: This retrospective study enrolled 83 treatment-experienced RA (TE-RA), 49 treatment-naïve RA (TN-RA), and 51 seropositive UA patients, as well as 60 healthy controls. Peripheral lymphocyte subsets and serum cytokines were profiled using flow cytometry and bead arrays. Least absolute shrinkage and selection operator (LASSO) regression was utilized to develop an immune-based derivation-stage classifier for distinguishing TN-RA from UA, with internal validation by bootstrap resampling (B = 1000). Results: Immunophenotypic analysis identified distinct immune profiles between TN-RA and UA at initial presentation. TN-RA was characterized by IL-2 signaling exhaustion (elevated sIL-2R, decreased IL-2), systemic inflammation (elevated IL-6, IFN-γ, and TNF-α), and compensatory memory Treg expansion (increased CD45RO+ Tregs). In contrast, UA exhibited a Th17/Treg imbalance with relatively preserved Th2 and Th17 responses. An eight-feature immune signature (sIL-2R, IL-6, CD45RO+ Tregs, CD45RO+ Treg%, IFN-γ, Th17/Treg ratio, Th2, Th17%) discriminated TN-RA from UA with an optimism-corrected AUC of 0.959 (95% CI: 0.923–0.995), adjusted for age, sex, BMI, and disease duration. sIL-2R and IL-6 were the strongest contributors, consistent with their central roles in RA pathophysiology. Conclusions: In the present study, an immune-based derivation-stage classifier showed potential for distinguishing TN-RA from UA at initial presentation. The IL-2-Treg axis perturbation represents a potential pathophysiological distinction, with sIL-2R as a candidate biomarker. These findings suggest that objective immune profiling may inform clinical decision-making when conventional criteria are inconclusive.
- 9 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1844268
Open AccessSoluble IL-2 receptor and memory Treg profiles differentiate early rheumatoid arthritis from undifferentiated arthritis at initial presentation
Background: Rheumatoid arthritis (RA) is a significant global health issue. Early diagnosis remains clinically challenging, particularly in patients with inflammatory arthritis who do not yet fulfill 2010 ACR/EULAR classification criteria (undifferentiated arthritis, UA). Methods: This retrospective study enrolled 83 treatment-experienced RA (TE-RA), 49 treatment-naïve RA (TN-RA), and 51 seropositive UA patients, as well as 60 healthy controls. Peripheral lymphocyte subsets and serum cytokines were profiled using flow cytometry and bead arrays. Least absolute shrinkage and selection operator (LASSO) regression was utilized to develop an immune-based derivation-stage classifier for distinguishing TN-RA from UA, with internal validation by bootstrap resampling (B = 1000). Results: Immunophenotypic analysis identified distinct immune profiles between TN-RA and UA at initial presentation. TN-RA was characterized by IL-2 signaling exhaustion (elevated sIL-2R, decreased IL-2), systemic inflammation (elevated IL-6, IFN-γ, and TNF-α), and compensatory memory Treg expansion (increased CD45RO+ Tregs). In contrast, UA exhibited a Th17/Treg imbalance with relatively preserved Th2 and Th17 responses. An eight-feature immune signature (sIL-2R, IL-6, CD45RO+ Tregs, CD45RO+ Treg%, IFN-γ, Th17/Treg ratio, Th2, Th17%) discriminated TN-RA from UA with an optimism-corrected AUC of 0.959 (95% CI: 0.923–0.995), adjusted for age, sex, BMI, and disease duration. sIL-2R and IL-6 were the strongest contributors, consistent with their central roles in RA pathophysiology. Conclusions: In the present study, an immune-based derivation-stage classifier showed potential for distinguishing TN-RA from UA at initial presentation. The IL-2-Treg axis perturbation represents a potential pathophysiological distinction, with sIL-2R as a candidate biomarker. These findings suggest that objective immune profiling may inform clinical decision-making when conventional criteria are inconclusive.
- 18 May 2026
- Published by Elsevier in Autoimmunity Reviews
- Vol. 25 (7) , 104077
Double-negative T cells in systemic lupus erythematosus: From immunopathology to therapeutic target
- 18 May 2026
- Published by Elsevier in Autoimmunity Reviews
- Vol. 25 (7) , 104077
Double-negative T cells in systemic lupus erythematosus: From immunopathology to therapeutic target
- Open Access
- 25 March 2026
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 28 (1)
Immunological and clinical predicators for venous thromboembolism in ANCA-associated vasculitis patients: elevated natural killer cells and cardiac involvement
The online version contains supplementary material available at 10.1186/s13075-026-03792-z.
- 25 March 2026
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 28 (1)
Open AccessImmunological and clinical predicators for venous thromboembolism in ANCA-associated vasculitis patients: elevated natural killer cells and cardiac involvement
The online version contains supplementary material available at 10.1186/s13075-026-03792-z.
- 23 February 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (3)
Distinct immunological features characterize early-onset primary Sjögren’s disease
Objectives: Early-onset primary Sjögren’s disease (pSjD) represents a specific clinical phenotype with poorer prognosis. We aim to compare early- and late-onset pSjD immunophenotypes to identify key distinct immunological features. Methods: We retrospectively studied 204 newly diagnosed, untreated pSjD patients categorized by age at diagnosis (≤35 years). Clinical features, peripheral lymphocyte profiles, CD4+ T cell subsets and cytokine levels were compared. Key immune variables were screened via random forest and LASSO regression. LASSO-selected variables were analysed using forward stepwise logistic regression to determine independent immune factors associated with early-onset pSjD. Results: Among 204 enrolled patients, 43 (21.08%) were classified as early-onset pSjD and 161 (78.92%) as late-onset pSjD. Compared with the late-onset group, early-onset patients showed significantly lower CD4+ T cell counts [442.62 (236.92–558.89) vs 563.11 (386.98–762.60), P = 0.005] and NK cell counts [71.36 (51.69–134.58) vs 138.05 (91.65–241.90), P < 0.001]. In terms of CD4+ T cell subsets, the early-onset group exhibited higher Th17/Treg cell ratios [0.42 (0.33–0.59) vs 0.30 (0.21–0.46), P = 0.006] and lower Treg cell counts [22.07 (12.89–34.96) vs 28.00 (20.35–38.93), P = 0.032]. Three independent factors for early-onset disease were identified: NK cell counts (OR = 0.993, P = 0.010), CD4+ T cell percentage (OR = 0.947, P = 0.019) and Th17/Treg cell ratios (OR = 5.215, P = 0.029). Conclusion: This study characterizes the distinct peripheral immunological landscapes of early- and late-onset pSjD and identifies an immunological triad that may represent a unique ‘immune endotype’ for early-onset disease, offering insights into targeted monitoring and therapies.
- 23 February 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (3)
Distinct immunological features characterize early-onset primary Sjögren’s disease
Objectives: Early-onset primary Sjögren’s disease (pSjD) represents a specific clinical phenotype with poorer prognosis. We aim to compare early- and late-onset pSjD immunophenotypes to identify key distinct immunological features. Methods: We retrospectively studied 204 newly diagnosed, untreated pSjD patients categorized by age at diagnosis (≤35 years). Clinical features, peripheral lymphocyte profiles, CD4+ T cell subsets and cytokine levels were compared. Key immune variables were screened via random forest and LASSO regression. LASSO-selected variables were analysed using forward stepwise logistic regression to determine independent immune factors associated with early-onset pSjD. Results: Among 204 enrolled patients, 43 (21.08%) were classified as early-onset pSjD and 161 (78.92%) as late-onset pSjD. Compared with the late-onset group, early-onset patients showed significantly lower CD4+ T cell counts [442.62 (236.92–558.89) vs 563.11 (386.98–762.60), P = 0.005] and NK cell counts [71.36 (51.69–134.58) vs 138.05 (91.65–241.90), P < 0.001]. In terms of CD4+ T cell subsets, the early-onset group exhibited higher Th17/Treg cell ratios [0.42 (0.33–0.59) vs 0.30 (0.21–0.46), P = 0.006] and lower Treg cell counts [22.07 (12.89–34.96) vs 28.00 (20.35–38.93), P = 0.032]. Three independent factors for early-onset disease were identified: NK cell counts (OR = 0.993, P = 0.010), CD4+ T cell percentage (OR = 0.947, P = 0.019) and Th17/Treg cell ratios (OR = 5.215, P = 0.029). Conclusion: This study characterizes the distinct peripheral immunological landscapes of early- and late-onset pSjD and identifies an immunological triad that may represent a unique ‘immune endotype’ for early-onset disease, offering insights into targeted monitoring and therapies.
- Open Access
- 26 November 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1693787
SPP1, LYZ, and MCM5: potential diagnostic biomarkers for rheumatoid arthritis and cervical cancer comorbidity
Background: The comorbidity of rheumatoid arthritis (RA), a chronic autoimmune disease, with cervical cancer has garnered a lot of attention. Cervical cancer is much more common in RA patients than in the general population, which may be caused by immunosuppressive therapy, chronic inflammation, and poor clearance of the Human Papillomavirus (HPV). The purpose of this study is to explore the molecular mechanism of comorbidity between RA and cervical cancer and identify potential biomarkers through transcriptomics and single cell transcriptomics analysis. Methods: In this study, transcriptome expression profile data of RA and cervical cancer were downloaded from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases, and differential gene analysis, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analysis were performed. Using multivariate Cox proportional hazard modeling and Lasso regression, independent differential genes linked to the prognosis of cervical cancer were screened. Molecular docking technology was used to predict the interaction between candidate gene encoded proteins and HPV 16 E6/E7. Intercellular communication and the expression patterns of potential genes in various cell groups were examined using single cell transcriptome data. Finally, the expression of candidate genes in cervical tissues of patients with RA combined with cervical cancer was verified by immunohistochemistry. Results: The study found that those with RA had 493 up-regulated genes and 216 down-regulated genes, while individuals with cervical cancer had 2,600 up-regulated genes and 2,172 down-regulated genes. Cox regression analysis identified 35 genes independently associated with the prognosis of cervical cancer, of which SPP1, LYZ, and MCM5 were significantly regulated in both RA and cervical cancer. The HPV 16 E6/E7 specific binding sites of the proteins produced by these three genes were shown using molecular docking simulation. Especially, single cell transcriptomic analysis revealed that SPP1 was highly expressed in NK/T cells, Myeloid cells, and epithelial cells, and served as an important ligand receptor pair for communication between these cells. Immunohistochemistry results further verified the high expression of SPP1, LYZ, and MCM5 in patients with RA combined with cervical cancer. Conclusion: This study successfully identified SPP1, LYZ, and MCM5 as key hub genes for the comorbidity of RA and cervical cancer. By regulating processes like inflammation, immune evasion, and cell proliferation, these genes not only have a high diagnostic potential but may also contribute to the occurrence and development of cervical cancer.
- 26 November 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1693787
Open AccessSPP1, LYZ, and MCM5: potential diagnostic biomarkers for rheumatoid arthritis and cervical cancer comorbidity
Background: The comorbidity of rheumatoid arthritis (RA), a chronic autoimmune disease, with cervical cancer has garnered a lot of attention. Cervical cancer is much more common in RA patients than in the general population, which may be caused by immunosuppressive therapy, chronic inflammation, and poor clearance of the Human Papillomavirus (HPV). The purpose of this study is to explore the molecular mechanism of comorbidity between RA and cervical cancer and identify potential biomarkers through transcriptomics and single cell transcriptomics analysis. Methods: In this study, transcriptome expression profile data of RA and cervical cancer were downloaded from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases, and differential gene analysis, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analysis were performed. Using multivariate Cox proportional hazard modeling and Lasso regression, independent differential genes linked to the prognosis of cervical cancer were screened. Molecular docking technology was used to predict the interaction between candidate gene encoded proteins and HPV 16 E6/E7. Intercellular communication and the expression patterns of potential genes in various cell groups were examined using single cell transcriptome data. Finally, the expression of candidate genes in cervical tissues of patients with RA combined with cervical cancer was verified by immunohistochemistry. Results: The study found that those with RA had 493 up-regulated genes and 216 down-regulated genes, while individuals with cervical cancer had 2,600 up-regulated genes and 2,172 down-regulated genes. Cox regression analysis identified 35 genes independently associated with the prognosis of cervical cancer, of which SPP1, LYZ, and MCM5 were significantly regulated in both RA and cervical cancer. The HPV 16 E6/E7 specific binding sites of the proteins produced by these three genes were shown using molecular docking simulation. Especially, single cell transcriptomic analysis revealed that SPP1 was highly expressed in NK/T cells, Myeloid cells, and epithelial cells, and served as an important ligand receptor pair for communication between these cells. Immunohistochemistry results further verified the high expression of SPP1, LYZ, and MCM5 in patients with RA combined with cervical cancer. Conclusion: This study successfully identified SPP1, LYZ, and MCM5 as key hub genes for the comorbidity of RA and cervical cancer. By regulating processes like inflammation, immune evasion, and cell proliferation, these genes not only have a high diagnostic potential but may also contribute to the occurrence and development of cervical cancer.